New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
R1 RCM Inc.
RCM
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

6B

Medical - Healthcare Information Services

Next Earning date - 07 Nov 2024

6B

Medical - Healthcare Information Services

Next Earning date - 07 Nov 2024

14.21USD
Shape-0.01 ( -0.07%)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

-79%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 12, 2024
1W 0.07 % 1M 0.64 % 3M 11.10 % 1Y 7.65 %

Key Metrics

Shape
  • Market Cap

    6.00B


  • Shares Outstanding

    422.11M


  • Share in Float

    156.89M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    14.21


  • Average Volume

    4.67M


  • Beta

    0.852


  • Range

    8.87-15.12


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.r1rcm.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.52x

P/S Ratio

2.12x

P/B Ratio

0.8

Debt/Equity

-1.7%

Net Margin

$-0.1

EPS

How RCM compares to sector?

P/E Ratio

Relative Strength

Shape

RCM

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape367%

2025-Revenue

$0.16

Shape1007%

2025-EPS

$432M

Shape201%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Underperform

2024-08-08

Now: Equal-Weight

Cowen & Co.

downgrade

Previous: Buy

2024-08-05

Now: Hold

Citigroup

downgrade

Previous: Not converted

2024-08-02

Now: Neutral

Cantor Fitzgerald

downgrade

Previous: Overweight

2024-08-01

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.07
vs 0.05

Q4.22

arrow
arrow

N/A

-0.09
vs 0.11

Q1.23

arrow
arrow

-99%

0
vs 0.09

Q2.23

arrow
arrow

-99%

0
vs 0.13

Q3.23

arrow
arrow

+104%

0
vs -0.07

Q4.23

arrow
arrow

+103%

0
vs -0.09

Q1.24

arrow
arrow

N/A

-0.08
vs 0

Q2.24

arrow
arrow

N/A

-0.02
vs 0

Q3.24

arrow
arrow

-30%

0
vs 0

Q4.24

arrow
arrow

+1158%

0.04
vs 0

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+31%

496M  vs 379.7M

Q4.22

arrow
arrow

+34%

532.8M  vs 398.9M

Q1.23

arrow
arrow

+41%

545.6M  vs 385.7M

Q2.23

arrow
arrow

+43%

560.7M  vs 391.9M

Q3.23

arrow
arrow

+15%

572.8M  vs 496M

Q4.23

arrow
arrow

+8%

575.1M  vs 532.8M

Q1.24

arrow
arrow

+11%

603.9M  vs 545.6M

Q2.24

arrow
arrow

+12%

627.9M  vs 560.7M

Q3.24

arrow
arrow

+12%

641.9M  vs 572.8M

Q4.24

arrow
arrow

+19%

681.7M  vs 575.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-1%

-0.01
vs -0.01

Q4.22

arrow
arrow

-1%

-0.01
vs -0.01

Q1.23

arrow
arrow

+0%

0
vs -0.01

Q2.23

arrow
arrow

+0%

0
vs 0

Q3.23

arrow
arrow

+0%

0
vs 0

Q4.23

arrow
arrow

+0%

0
vs 0

Q1.24

arrow
arrow

-1%

-0.01
vs 0

Q2.24

arrow
arrow

0%

-0.00
vs -0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

244

244
vs 229

7%

Q4.22

arrow
arrow

240

240
vs 244

-2%

Q1.23

arrow
arrow

241

241
vs 240

0%

Q2.23

arrow
arrow

235

235
vs 241

-2%

Q3.23

arrow
arrow

234

234
vs 235

0%

Q4.23

arrow
arrow

264

264
vs 234

13%

Q1.24

arrow
arrow

270

270
vs 264

2%

Q2.24

arrow
arrow

275

275
vs 270

2%

Earnings Growth

Latest News